Tennis elbow breakthrough? study seeks to predict PRP winners
NCT ID NCT07496983
First seen Apr 07, 2026 · Last updated May 06, 2026 · Updated 4 times
Summary
This study looks at 139 adults with chronic tennis elbow who recently received a platelet-rich plasma (PRP) injection. Researchers want to find out how many people respond to PRP and what factors—like age, job, or medical history—might predict a good response. Participants are followed for 90 days with pain and function tests. The goal is to help doctors identify who is most likely to benefit from PRP in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LATERAL EPICONDYLITIS OF THE ELBOW are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles (CMRRF) de Kerpape
RECRUITINGPloemeur, 56270, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.